Merus N.V. (MRUS)
NASDAQ: MRUS · IEX Real-Time Price · USD
47.93
+0.90 (1.92%)
May 2, 2024, 2:39 PM EDT - Market open

Merus Revenue

In the year 2023, Merus had annual revenue of $43.95M with 5.68% growth. Revenue in the quarter ending December 31, 2023 was $8.94M, a -16.19% decrease year-over-year.

Revenue (ttm)
$43.95M
Revenue Growth
+5.68%
P/S Ratio
63.22
Revenue / Employee
$191,908
Employees
229
Market Cap
2.78B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202343.95M2.36M5.68%
Dec 31, 202241.59M-7.52M-15.32%
Dec 31, 202149.11M19.16M64.00%
Dec 31, 202029.94M-1.19M-3.82%
Dec 31, 201931.13M-7.25M-18.88%
Dec 31, 201838.38M14.27M59.20%
Dec 31, 201724.11M21.35M773.11%
Dec 31, 20162.76M665.50K31.76%
Dec 31, 20152.10M662.20K46.20%
Dec 31, 20141.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 3.00B
Premier 1.32B
Indivior 1.12B
Neogen 929.24M
PTC Therapeutics 927.56M
MorphoSys AG 264.75M
PROCEPT BioRobotics 136.19M
Celldex Therapeutics 6.88M
Revenue Rankings